Solid Biosciences Price To Sales Ratio Over Time
| SLDB Stock | USD 3.19 0.07 2.15% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Solid Biosciences Performance and Solid Biosciences Correlation. Solid |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare Solid Biosciences LLC and related stocks such as Century Therapeutics, Edgewise Therapeutics, and C4 Therapeutics Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSC | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 56.9893 | 88.1091 | 79.3 | 58.04 |
| EWTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| CCCC | 19.4664 | 19.4664 | 19.4664 | 19.4664 | 19.4664 | 19.4664 | 19.4664 | 19.4664 | 19.4664 | 51.2461 | 42.9753 | 32.3806 | 9.2708 | 13.5127 | 15.54 | 30.95 |
| MLYS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| CGEM | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 36.0781 | 32.47 | 28.86 |
| RVMD | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 52.2724 | 34.0746 | 61.3425 | 62.3521 | 54.2828 | 280 | 252 | 265 |
| BDTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PASG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ANEB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ACRV | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PMVP | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| MOLN | 13.6455 | 13.6455 | 13.6455 | 13.6455 | 12.975 | 23.4861 | 21.9882 | 27.4113 | 37.4097 | 18.4056 | 55.5184 | 59.2189 | 1.0552 | 16.0175 | 14.42 | 20.88 |
| STOK | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 28.9418 | 26.3568 | 30.31 | 30.42 |
| GLUE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| CABA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| LRMR | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ALEC | 2.2 K | 2.2 K | 2.2 K | 2.2 K | 2.2 K | 2.2 K | 2.2 K | 247 | 44.4619 | 50.1289 | 55.7631 | 8.019 | 5.6967 | 6.8842 | 7.92 | 7.52 |
Solid Biosciences LLC and related stocks such as Century Therapeutics, Edgewise Therapeutics, and C4 Therapeutics Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Solid Biosciences LLC stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Solid Biosciences sales, a figure that is much harder to manipulate than other Solid Biosciences LLC multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Solid Biosciences LLC | SLDB |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.19
Check out Solid Biosciences Performance and Solid Biosciences Correlation. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Solid Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.